指南与共识创伤与烧伤重症综合管理与镇静镇痛

外科感染学会:胸壁损伤学会关于创伤性肋骨或胸骨骨折手术稳定术中抗生素使用以降低植入物感染风险的建议

Surgical Infection Society: Chest Wall Injury Society Recommendations for Antibiotic Use during Surgical Stabilization of Traumatic Rib or Sternal Fractures to Reduce Risk of Implant Infection.
指南 / 共识 · Surg Infect (Larchmt) · 2022-01-01
一句话结论对于无感染或污染证据的肋骨/胸骨骨折手术稳定患者,现有围手术期指南或建议已足够;合并脓毒症、肺炎、脓胸或开放性/污染胸腔时证据不足,可参照相应感染指南。

该指南由外科感染学会治疗与指南委员会及胸壁损伤学会出版委员会共同制定,针对创伤性肋骨骨折手术稳定(SSRF)或胸骨骨折手术稳定(SSSF)围手术期抗生素使用提出建议。委员会检索PubMed、Embase和Cochrane数据库,通过迭代共识投票形成推荐。对于无既存感染过程者,证据不足以表明现有围手术期指南或建议不充分;对于合并脓毒症、肺炎或脓胸者,证据不足以就抗生素疗程和选择给出推荐,可由相应感染指南指导;对于开放性或污染胸腔者,证据不足以提供具体抗生素建议。

要点

  • 无既存感染过程行SSRF或SSSF者,证据不足以表明现有围手术期指南或建议不充分。
  • 合并脓毒症、肺炎或脓胸行SSRF或SSSF者,证据不足以就抗生素疗程和选择给出推荐,可由相应感染指南指导。
  • 开放性胸腔或污染胸腔行SSRF或SSSF者,证据不足以提供具体抗生素建议。
  • 胸壁手术稳定文献证据有限,需进一步研究明确合并感染过程患者植入物感染风险。

适用人群与场景

  • 接受外科肋骨骨折稳定(SSRF)或胸骨骨折稳定(SSSF)的创伤性肋骨或胸骨骨折患者。
  • 临床场景包括术时即存在创伤所致合并感染过程(脓毒症、肺炎、脓胸、蜂窝织炎)或污染来源(开放性胸腔、肉眼污染)的患者。

处置流程与药物剂量

  • 无既存感染过程行SSRF或SSSF者:证据不足以表明现有围手术期指南或建议不充分。
  • 合并脓毒症、肺炎或脓胸行SSRF或SSSF者:证据不足以就抗生素疗程和选择给出推荐;该决定可由相应合并感染的现有指南指导。
  • 开放性胸腔或污染胸腔行SSRF或SSSF者:证据不足以提供具体抗生素建议。

研究设计与关键结果

  • 制定机构为外科感染学会治疗与指南委员会及胸壁损伤学会出版委员会;方法为检索PubMed、Embase和Cochrane数据库,通过迭代共识由全体委员会成员投票接受或拒绝每条建议。

证据类型、等级与局限

  • 证据类型:指南;证据不足以就多个临床场景给出具体推荐。
  • 局限:胸壁手术稳定文献证据有限,需进一步研究明确合并感染过程患者植入物感染风险。

对床旁实践的改变

  • 无既存感染过程行SSRF或SSSF者,现有围手术期指南或建议不充分这一说法证据不足,可继续按现有围手术期指南执行。
  • 合并脓毒症、肺炎或脓胸行SSRF或SSSF者,抗生素疗程和选择无具体推荐,可由相应感染指南指导决策。
  • 开放性胸腔或污染胸腔行SSRF或SSSF者,无具体抗生素建议。

指南或共识出处

  • 指南名称:外科感染学会:胸壁损伤学会关于创伤性肋骨或胸骨骨折手术稳定术中抗生素使用以降低植入物感染风险的建议;发布机构:外科感染学会、胸壁损伤学会;发表于Surg Infect (Larchmt)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Surgical stabilization of rib fractures is recommended in patients with flail chest or multiple displaced rib fractures with physiologic compromise. Surgical stabilization of rib fractures (SSRF) and surgical stabilization of sternal fractures (SSSF) involve open reduction and internal fixation of fractures with a plate construct to restore anatomic alignment. Most plate constructs are composed of titanium and presence of this foreign, non-absorbable material presents opportunity for implant infection. Although implant infection rates after SSRF and SSSF are low, they present a challenging clinical entity often requiring prolonged antibiotic therapy, debridement, and potentially implant removal. Methods: The Surgical Infection Society's Therapeutics and Guidelines Committee and Chest Wall Injury Society's Publication Committee convened to develop recommendations for antibiotic use during and after surgical stabilization of traumatic rib and sternal fractures. Clinical scenarios included patients with concomitant infectious processes (sepsis, pneumonia, empyema, cellulitis) or sources of contamination (open chest, gross contamination) incurred as a result of their trauma and present at the time of their surgical stabilization. PubMed, Embase, and Cochrane databases were searched for pertinent studies. Using a process of iterative consensus, all committee members voted to accept or reject each recommendation. Results: For patients undergoing SSRF or SSSF in the absence of pre-existing infectious process, there is insufficient evidence to suggest existing peri-operative guidelines or recommendations are inadequate. For patients undergoing SSRF or SSSF in the presence of sepsis, pneumonia, or an empyema, there is insufficient evidence to provide recommendations on duration and choice of antibiotic. This decision may be informed by existing guidelines for the concomitant infection. For patients undergoing SSRF or SSSF with an open or contaminated chest there is insufficient evidence to provide specific antibiotic recommendations. Conclusions: This guideline document summarizes the current Surgical Infection Society and Chest Wall Injury Society recommendations regarding antibiotic use during and after surgical stabilization of traumatic rib or sternal fractures. Limited evidence exists in the chest wall surgical stabilization literature and further studies should be performed to delineate risk of implant infection among patients undergoing SSSRF or SSSF with concomitant infectious processes.

来源:Surg Infect (Larchmt),查看原文。版权归原作者所有。

参考来源

  1. Forrester JD, Bukur M, Dvorak JE, et al. Surgical Infection Society: Chest Wall Injury Society Recommendations for Antibiotic Use during Surgical Stabilization of Traumatic Rib or Sternal Fractures to Reduce Risk of Implant Infection. Surg Infect (Larchmt). 2022. PMID: 35522129. doi:10.1089/sur.2022.025

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。